Flow cytometry-based evaluation of CD4/CD25 and IL-17 expression in sepsis of cancer surgical patients
International Journal of Immunopathology and Pharmacology · 2025
DOI: 10.1177/03946320251375162 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2025. Verfasst von Ahmed Samir Abdelhafiz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Sepsis, Interleukin-17, Interleukin-2 Receptor alpha Subunit, Flow Cytometry. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Introduction and objectives: Sepsis is a critical, life-threatening condition marked by organ dysfunction. Patients undergoing surgery for cancer are especially susceptible, facing a significantly increased risk compared to the general population. Prompt diagnosis is essential for optimal treatment outcomes. This study investigates the expression levels of IL-17 and CD4/CD25 in postoperative surgical oncology patients diagnosed with sepsis and examines their association with various clinicopathological parameters, including mortality.
Methods
Peripheral blood samples were collected 48 h following admission to the surgical ICU. Flow cytometry was employed to measure the expression of IL-17 and CD4/CD25 in both septic patients and non-septic controls.
Results
The study included 30 septic patients and an equal number of controls. The expression of IL-17 and CD4/CD25 was significantly higher in septic patients compared to non-septic patients, demonstrating high diagnostic performance. Additionally, elevated IL-17 expression was strongly associated with an increased risk of mortality.
Conclusion
Our study provides insight into immune dysregulation in postoperative cancer patients with sepsis, highlighting the dual arms of active inflammation and immunoparalysis. Elevated IL-17 levels, coupled with Treg activation, were linked to poorer outcomes. Therapeutic strategies that target IL-17 signaling and modulate Treg activity may help restore immune balance and improve prognosis in immunocompromised individuals. Furthermore, developing predictive models using machine learning to classify sepsis severity based on immune markers could enhance diagnosis and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
- Department of Pulmonary Medicine, Abbassia Chest Hospital, Ministry of Health and Population, Cairo, Egypt.
- Department of Anesthesia, Surgical Critical Care and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.
ORCID-Profile: Ahmed Samir Abdelhafiz
Zitieren
APA
Abdelhafiz, A. S., Ali, A., Elsabeeny, W. Y., Fahmy, A., Fouda, M. A., Ayoub, M. A., & Hanafi, M. (2025). Flow cytometry-based evaluation of CD4/CD25 and IL-17 expression in sepsis of cancer surgical patients. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320251375162
Vancouver
Abdelhafiz AS, Ali A, Elsabeeny WY, Fahmy A, Fouda MA, Ayoub MA, et al. Flow cytometry-based evaluation of CD4/CD25 and IL-17 expression in sepsis of cancer surgical patients. International Journal of Immunopathology and Pharmacology. 2025. doi:10.1177/03946320251375162
BibTeX
@article{Abdelhafiz2025,
author = {Abdelhafiz, Ahmed Samir and Ali, Asmaa and Elsabeeny, Walaa Y and Fahmy, Ahmed and Fouda, Merhan A and Ayoub, Mahmoud Ali and Hanafi, Marwa},
title = {Flow cytometry-based evaluation of CD4/CD25 and IL-17 expression in sepsis of cancer surgical patients},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2025},
doi = {10.1177/03946320251375162}
}
EUVIMED